Nektar TherapeuticsNKTR
那斯達克 · USD
74.19
-2.18
(-2.85%)
收盤 09/05 03:59 (UTC+8)
09/05 03:59 (UTC+8)
Nektar TherapeuticsNKTR
74.19
-2.18
(-2.85%)
財務數據
損益表
- 0.22
- 0.23
- 0.24
- 0.29
- 0.10
- 0.11
- 0.12
- 0.22
- 0.11
- 0.10
- -9.40
- 8.55
- 2.70
- 20.94
- -64.15
- 6.84
- 5.50
- 84.96
- -50.19
- -6.72
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 10,131 | 10,861 | 21,807 | 11,790 | 11,175 | 10,460 | 29,175 | 24,124 | 23,489 | 21,639 |
營業成本 | - | - | - | - | - | - | 7,977 | 4,435 | 9,740 | 8,534 |
營業毛利 | 10,131 | 10,861 | 21,807 | 11,790 | 11,175 | 10,460 | 21,198 | 19,689 | 13,749 | 13,105 |
營業費用 | 52,472 | 49,915 | 49,472 | 43,462 | 47,405 | - | 47,240 | - | - | 48,532 |
研發費用 | 39,129 | 35,680 | 29,712 | 27,252 | 29,886 | 30,480 | 28,745 | 35,031 | 29,724 | 27,408 |
推銷及管理費用 | 12,765 | 13,439 | 11,185 | 16,070 | 17,072 | 24,346 | 17,135 | 18,957 | 20,510 | 20,149 |
非經常性項目費用 | 578 | 796 | 8,575 | 140 | 447 | 169 | 1,360 | 46 | 13,289 | 975 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -42,341 | -39,054 | -27,665 | -31,672 | -36,230 | -44,535 | 14,348 | -34,345 | -49,774 | -35,427 |
其他收入及費用 | 9,246 | 3,906 | 2,732 | 2,698 | 2,229 | 3,140 | 43,197 | 3,317 | 3,865 | 4,121 |
利息費用 | 7,206 | 7,942 | 9,769 | 6,047 | 5,394 | 4,974 | 10,153 | 6,020 | 6,408 | 5,531 |
稅前純益 | -40,301 | -43,090 | -34,702 | -35,021 | -39,395 | -46,369 | 7,002 | -37,048 | -52,317 | -36,837 |
所得稅 | 2 | 64 | 31 | -33 | -188 | 52 | -259 | 9 | 46 | -35 |
稅後純益 | -40,622 | -44,904 | -36,079 | -35,522 | -41,593 | -50,882 | 7,261 | -37,057 | -52,363 | -36,802 |
基本每股稅後盈餘(元) | -1.23 | -1.82 | -1.78 | -1.87 | -2.95 | -0.24 | 0.03 | 0.18 | -0.25 | -0.19 |
稀釋每股稅後盈餘(元) | -1.14 | -1.82 | -1.59 | -1.87 | -2.95 | -0.24 | 0.04 | -0.18 | -0.25 | -0.19 |
基本平均股數(千股) | 33054.00 | 24736.00 | 20296.00 | 18946.00 | 14087.00 | 210913.00 | 209726.00 | 209237.00 | 208810.00 | 194746.00 |
稀釋平均股數(千股) | 33054.00 | 24736.00 | 20296.00 | 18946.00 | 14087.00 | 210913.00 | 213583.00 | 209237.00 | 208810.00 | 194746.00 |
還原基本每股稅後盈餘(元) | -1.23 | -1.82 | -1.78 | -1.87 | -2.95 | -3.60 | 0.45 | 2.66 | -3.76 | -2.85 |
還原稀釋每股稅後盈餘(元) | -1.14 | -1.82 | -1.59 | -1.87 | -2.95 | -3.62 | 0.59 | -2.70 | -3.75 | -2.85 |
還原基本平均股數(千股) | 33,054 | 24,736 | 20,296 | 18,946 | 14,087 | 14,061 | 13,982 | 13,949 | 13,921 | 12,983 |
還原稀釋平均股數(千股) | 33,054 | 24,736 | 20,296 | 18,946 | 14,087 | 14,061 | 14,239 | 13,949 | 13,921 | 12,983 |
EBITDA(千元) | -36,828 | -38,410 | -27,977 | -30,745 | -37,042 | -46,754 | 15,953 | -32,099 | -47,034 | -32,762 |